OBJECTIVE - Although postchallenge hyperglycemia is a well-established feat
ure of type 2 diabetes, its association with risk of mortality is uncertain
. Therefore, the aim of this study was, to assess the independent associati
on of fasting and 2-h glucose levels with all-cause and cardiovascular dise
ase (CVD) mortality.
RESEARCH DESIGN AND METHODS - We analyzed data from the Second National Hea
lth and Nutrition Examination Survey (NHANES 11) Mortality Study, a prospec
tive cohort study of U.S. adults examined in the NHANES 11, and focused on
the 3,092 adults aged 30-74 years who underwent an oral glucose tolerance t
est at. baseline (1976-1980). Deaths were identified from U.S. national mor
tality files from 1976 to 1992, To account for the complex survey design, w
e used SUDAAN statistical software for weighted analysis.
RESULTS - Compared with their normoglycemic counterparts (fasting glucose [
FG] <7.0 and 2-h glucose <7.8 mmol/l), adults with fasting and postchalleng
e hyperglycemia (FG greater than or equal to7.0 and 2-h glucose greater tha
n or equal to 11.1 mmol/l) had a twofold higher risk of death after 16 year
s of follow-up (age- and sex-adjusted relative hazard [RH] 2.1, 95% CI 1.4-
3.2). However, adults with isolated postchallenge hyperglycemia (FG <7.0 an
d 2-h glucose <greater than or equal to>11.1 mmol/l) were also at higher ri
sk of death (1.6, 1.0-2.6). In proportional hazards analysis, FG (fully adj
usted RH 1.10 per I SD AND 95% CI 1.01, 1.22) and 2-h glucose (1, 14, 1.00-
1.29) showed nearly identical predictive value for mortality. Similar trend
s were observed for CVD mortality.
CONCLUSIONS - These results suggest that postchallenge hyperglycemia is ass
ociated with increased risk of all-cause and CVD mortality independently of
Other CVD risk factors.